Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Certolizumab Pegol for the Treatment of Moderate to Severe Ulcerative Colitis: An Open Label Study

NCT01090154 is registered in ClinicalTrials.gov with University of Washington as lead sponsor.

NCT NCT01090154
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01090154 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Certolizumab Pegol for the Treatment of Moderate to Severe Ulcerative Colitis: An Open Label Study
Lead sponsor
University of Washington
Phase
Phase 2
Overall status
Completed
Start date
December 1, 2010
Completion date
December 10, 2021
Enrollment
27 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

ulcerative colitis